Disc Medicine, Inc. 8-K

What Happened

• Disc Medicine, Inc. (IRON) announced its financial results for the fourth quarter and fiscal year ended December 31, 2025, and provided a corporate update in a press release dated February 26, 2026. The company filed a Current Report on Form 8-K (Item 2.02) to disclose these results and updates.

Key Details

• Filing date: February 26, 2026 (Form 8-K covering Item 2.02: Results of Operations and Financial Condition).
• Reporting period: Fourth quarter and fiscal year ended December 31, 2025.
• Press release furnished as Exhibit 99.1 to the Form 8-K.
• Form 8-K signed by CEO John Quisel, J.D., Ph.D., on behalf of Disc Medicine.

Why It Matters

• This 8-K signals that the company has released its latest quarterly and annual earnings and a corporate update; investors should read the furnished press release (Exhibit 99.1) for details on revenue, expenses, cash position, guidance, and program updates.
• Timely review of the announced results can affect investor decisions about share valuation, financing needs, and progress of Disc Medicine’s clinical or commercial programs.